Opportunity Information: Apply for RFA DK 17 022
This NIH funding opportunity (RFA-DK-17-022) supports cooperative agreement (U01) projects aimed at mapping and explaining the human pancreatic islet tissue environment at much higher resolution than has typically been possible. The central goal is to improve understanding of how the islet and the tissue around it are physically organized and how that organization relates to function, dysfunction, and disease biology, especially in the context of type 1 diabetes (T1D). The emphasis is on human biology and human tissue structure and function rather than relying on rodent or other animal models, and the announcement explicitly states that it does not support clinical trials.
Scientifically, applicants are expected to focus on the composition and behavior of key elements of the islet and peri-islet architecture. That includes detailing which cell types and subtypes are present, what molecular signals they express, and what functional roles they play within the local pancreatic ecosystem. A major theme is understanding cell-to-cell relationships: how endocrine cells, immune cells, stromal and vascular components, and other resident or infiltrating populations interact; how they communicate through direct contact or secreted factors; and how these interactions influence beta cell health, stress, or loss. The FOA also encourages projects that look beyond the islet itself to examine how adjacent pancreatic compartments such as acinar tissue, ducts, and lymphatics shape islet function, as well as how neighboring tissues (including intestinal, mesenteric, and adipose tissues) may contribute to islet performance or dysfunction through regional signaling, immune trafficking, or metabolic cross-talk.
Programmatically, funded teams become part of the Human Pancreas Analysis Consortium (HPAC), which is designed to integrate closely with the Human Pancreas Analysis Program (HPAP). HPAP was launched earlier as a resource-generation effort to collect and distribute human pancreatic tissues and related datasets, and this FOA positions HPAC as an added layer that performs deeper, collaborative analyses to extract biological insight from those resources. HPAC is also described as the fifth consortium under the broader Human Islet Research Network (HIRN). In practical terms, this means awardees should anticipate a collaborative, networked structure typical of U01 mechanisms, where milestones, data sharing, coordination activities, and participation in consortium efforts are not optional add-ons but core expectations of the award.
The larger mission connection is directly tied to HIRN priorities: understanding how functional human beta cell mass is lost in T1D and identifying strategies to protect and replace beta cells. While the work supported here is not interventional clinical testing, the intended value is translational, meaning it should generate knowledge about human tissue organization, intercellular communication, and disease mechanisms that can later inform therapeutic concepts or guide future clinical research. Projects that meaningfully improve the field's ability to describe and interpret human islet microenvironments, particularly in ways that clarify pathways to beta cell failure or immune-mediated damage, are aligned with the announcement's purpose.
Eligibility is broad and includes many organizational types, such as public and private institutions of higher education, nonprofits (with and without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and multiple levels of government (state, county, city/township, special districts), as well as federally recognized tribal governments and tribal organizations. The announcement also highlights additional eligible applicant categories including minority-serving institutions (such as HBCUs, Hispanic-serving institutions, AANAPISI institutions, Alaska Native and Native Hawaiian Serving Institutions, and TCCUs), faith-based or community-based organizations, U.S. territories or possessions, and non-U.S. (foreign) organizations and regional organizations, indicating an intent to welcome diverse institutional participation.
Key administrative details in the source listing include: the sponsoring agency is the National Institutes of Health; the funding instrument is a cooperative agreement (U01); the activity area is health (CFDA 93.847); the original closing date was May 10, 2018; and the listed award ceiling is $550,000. The listing does not specify the number of expected awards in the provided fields, but it makes clear that funded projects will operate as coordinated components of HPAC and will be expected to integrate with HPAP and the broader HIRN structure.Apply for RFA DK 17 022
- The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
- This funding opportunity was created on 2018-02-15.
- Applicants must submit their applications by 2018-05-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $550,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is an NIH funding opportunity announcement identified as RFA-DK-17-022. It supports research projects, funded as cooperative agreements (U01), focused on mapping and explaining the human pancreatic islet tissue environment at much higher resolution than has typically been possible.
What is the main scientific goal of the program?
The central goal is to improve understanding of how the pancreatic islet and the tissue around it are physically organized, and how that organization relates to function, dysfunction, and disease biology, especially in the context of type 1 diabetes (T1D).
Is this opportunity focused on human studies or animal models?
The emphasis is on human biology and human tissue structure and function rather than relying on rodent or other animal models.
Does this funding opportunity support clinical trials?
No. The announcement explicitly states that it does not support clinical trials.
What types of biological questions are applicants expected to address?
Applicants are expected to focus on the composition and behavior of key elements of islet and peri-islet architecture. This includes identifying which cell types and subtypes are present, what molecular signals they express, and what functional roles they play within the local pancreatic ecosystem.
What kinds of cell-to-cell interactions are emphasized?
A major theme is understanding cell-to-cell relationships within the local pancreatic environment, including how endocrine cells, immune cells, stromal and vascular components, and other resident or infiltrating populations interact; how they communicate through direct contact or secreted factors; and how these interactions influence beta cell health, stress, or loss.
Is the focus limited to the islet itself?
No. The FOA encourages projects that look beyond the islet to examine adjacent pancreatic compartments such as acinar tissue, ducts, and lymphatics and how they shape islet function.
Does the FOA encourage studying tissues outside the pancreas?
Yes. It notes that neighboring tissues, including intestinal, mesenteric, and adipose tissues, may contribute to islet performance or dysfunction through regional signaling, immune trafficking, or metabolic cross-talk.
How does this opportunity connect to type 1 diabetes (T1D)?
The work is intended to clarify human islet microenvironments and disease mechanisms, particularly pathways to beta cell failure or immune-mediated damage, with a specific emphasis on T1D.
What is the intended impact of the research if it is not a clinical trial?
While the supported work is not interventional clinical testing, it is intended to be translational by generating knowledge about human tissue organization, intercellular communication, and disease mechanisms that can inform therapeutic concepts or guide future clinical research.
What funding mechanism is used for awards under this opportunity?
Awards are made as cooperative agreements (U01). This structure is described as collaborative and networked, with expectations around milestones, data sharing, coordination, and participation in consortium efforts.
What is HPAC and what does participation mean for awardees?
Funded teams become part of the Human Pancreas Analysis Consortium (HPAC). Participation is not described as optional; awardees should anticipate consortium-style expectations typical of U01 mechanisms, including coordination activities, collaboration, and integration with consortium goals.
How is HPAC related to HPAP?
HPAP (Human Pancreas Analysis Program) is described as a resource-generation effort to collect and distribute human pancreatic tissues and related datasets. This FOA positions HPAC as an added layer that performs deeper, collaborative analyses to extract biological insight from HPAP resources.
How is this opportunity related to HIRN?
HPAC is described as the fifth consortium under the Human Islet Research Network (HIRN). The broader mission alignment includes understanding how functional human beta cell mass is lost in T1D and identifying strategies to protect and replace beta cells.
Who is the sponsoring agency?
The sponsoring agency listed is the National Institutes of Health (NIH).
What is the activity area and CFDA number associated with this opportunity?
The activity area is health, and the CFDA number provided is 93.847.
Who is eligible to apply?
Eligibility is broad and includes public and private institutions of higher education; nonprofits (with and without 501(c)(3) status); for-profit organizations (other than small businesses); small businesses; and government entities at multiple levels (state, county, city/township, and special districts). It also includes federally recognized tribal governments and tribal organizations.
Are foreign or non-U.S. organizations eligible?
Yes. The opportunity specifically includes non-U.S. (foreign) organizations and regional organizations among eligible applicants.
Are minority-serving institutions and community-based organizations eligible?
Yes. The announcement highlights additional eligible applicant categories including minority-serving institutions (such as HBCUs, Hispanic-serving institutions, AANAPISI institutions, Alaska Native and Native Hawaiian Serving Institutions, and TCCUs), as well as faith-based or community-based organizations.
Are U.S. territories or possessions included in eligibility?
Yes. U.S. territories or possessions are explicitly listed among eligible applicant categories.
What is the award ceiling listed for this opportunity?
The listed award ceiling is $550,000.
When was the original closing date?
The original closing date listed is May 10, 2018.
Is the expected number of awards provided?
No. The provided fields do not specify the number of expected awards.
What are some of the key expectations for funded projects under the U01 cooperative agreement?
Based on the description, funded projects are expected to operate as coordinated components of HPAC, integrate with HPAP resources and efforts, and participate in the broader HIRN structure. Milestones, data sharing, coordination activities, and consortium participation are described as core expectations rather than optional add-ons.
Browse more opportunities from the same category: Food and Nutrition, Health
Next opportunity: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations An ORWH FY18 Administrative Supplement (Admin Supp - Clinical Trial Optional)
Previous opportunity: Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DK 17 022
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DK 17 022) also looked into and applied for these:
| Funding Opportunity |
|---|
| Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 - Clinical Trial Not Allowed) Apply for RFA DK 17 021 Funding Number: RFA DK 17 021 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $500,000 |
| Impact of the Use of Glucose Monitoring and Control Technologies on Health Outcomes and Quality of Life in Older Adults with Type 1 Diabetes (T1D) (R01 Clinical Trial Required) Apply for RFA DK 17 024 Funding Number: RFA DK 17 024 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $500,000 |
| Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01- Clinical Trial Optional) Apply for RFA DK 17 025 Funding Number: RFA DK 17 025 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $500,000 |
| Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional) Apply for RFA DK 18 004 Funding Number: RFA DK 18 004 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $500,000 |
| High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) Apply for PAS 18 698 Funding Number: PAS 18 698 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional) Apply for PAS 18 730 Funding Number: PAS 18 730 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $200,000 |
| Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed) Apply for PA 18 741 Funding Number: PA 18 741 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $200,000 |
| Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-associated Variants (R01 Clinical Trial Not Allowed) Apply for RFA DK 18 005 Funding Number: RFA DK 18 005 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $600,000 |
| Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional) Apply for PAR 18 743 Funding Number: PAR 18 743 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $200,000 |
| Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional) Apply for PAR 18 744 Funding Number: PAR 18 744 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $200,000 |
| Understanding Skeletal Effects of Type 1 Diabetes (R01 Clinical Trial Optional) Apply for RFA DK 18 002 Funding Number: RFA DK 18 002 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $400,000 |
| Regenerative Medicine Innovation Projects (RMIP) (U44 - Clinical Trial Not Allowed) Apply for RFA HL 18 035 Funding Number: RFA HL 18 035 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $225,000 |
| Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Studies (Collaborative U01 Clinical Trial Not Allowed) Apply for RFA HL 18 030 Funding Number: RFA HL 18 030 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $250,000 |
| Regenerative Medicine Innovation Projects (RMIP) (UT2 - Clinical Trial Not Allowed) Apply for RFA HL 18 033 Funding Number: RFA HL 18 033 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $225,000 |
| Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required) Apply for RFA HL 18 031 Funding Number: RFA HL 18 031 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $405,000 |
| New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional) Apply for PAR 18 886 Funding Number: PAR 18 886 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional) Apply for PA 18 891 Funding Number: PA 18 891 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional) Apply for PAR 18 898 Funding Number: PAR 18 898 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: Case Dependent |
| Human Islet Research Network - Consortium on Human Islet Biomimetics (HIRN-CHIB) (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA DK 18 011 Funding Number: RFA DK 18 011 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $750,000 |
| Pilot and Feasibility Clinical and Translational Research Studies in Digestive Diseases and Nutrition (R21 Clinical Trial Optional) Apply for PA 18 903 Funding Number: PA 18 903 Agency: National Institutes of Health Category: Food and Nutrition, Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 17 022", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
